Search

everythinglearnresearchcommunity

for

Search:↓

Doctors used a special blood sampling technique to diagnose a woman's rare ovarian tumor that was producing male hormones.

The mouse models are effective for testing new hair loss treatments.

Low-dose glucocorticoid treatment improves pregnancy and birth rates in women with nonclassical 21-hydroxylase deficiency.

Women with certain types of hair loss may have low iron levels.

Both finasteride and drospirenone effectively manage PCOS symptoms, but drospirenone is more effective in reducing ovarian volume and androgen levels.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Testosterone may slow down wound healing and increase inflammation.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

Tamoxifen may cause female hair loss by increasing androgen receptor expression.

The survey helps identify menstrual irregularities and excess male hormones, aiming to detect conditions like Polycystic Ovary Syndrome.

DHT reduces a cell's ability to promote hair growth, while 3D culture without DHT improves it.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

Women with excess body hair feel psychological distress influenced by societal beauty standards, but distress isn't directly linked to the amount of hair.

Androgens like testosterone affect hair growth and oil production differently across body parts and individuals.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Oxidative stress, not insulin resistance, is significantly related to free androgen index in PCOS.

Thyroid hormones and androgens affect gene expression in frog reproductive organs differently between males and females.

Finasteride does not prevent bladder cancer.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Certain miRNAs may play a role in sheep hair follicle development, which could help improve wool production.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Free Testosterone Index, bioavailable testosterone, and androstenedione are the most accurate for diagnosing excess male hormones in PCOS.